City

Jacksonville (2)

Rochester (2)

Houston (1)

Pittsburgh (1)

Scottsdale (1)

Winston-Salem (1)

Overall Status

Completed (2)

Active, not recruiting (1)

Phase

phase 2 (3)

Sponsor

Mayo Clinic (2)

M.D. Anderson Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (3)

Intervention

avelumab (1)

cisplatin (1)

erlotinib hydrochloride (1)

fluorouracil (1)

gemcitabine hydrochloride (1)

mitomycin (1)

quality-of-life assessment (1)

radiation therapy (1)

Study Documents

Intervention Type

drug (3)

other (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

stage ii renal pelvis cancer ajcc v8

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

Active, not recruiting

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
+17 more

Gemcitabine Hydrochloride

Jacksonville, Florida
+3 more

Jul 5, 2022

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8, Stage II Renal Pelvis Cancer

Completed

Has Results

Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
+11 more

Avelumab
+5 more

Scottsdale, Arizona
+2 more

Mar 12, 2021

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed

Has Results

Recurrent Bladder Urothelial Carcinoma
+19 more

Erlotinib Hydrochloride

Houston, Texas

M D Anderson Cancer Center

Aug 21, 2020